CFO
Cohance Lifesciences Limited
Equibles does not estimate personal net worth.
Himanshu Agarwal is recorded as CFO at Cohance Lifesciences Limited. Himanshu Agarwal has spoken on 2 earnings calls across 1 company, most recently for Cohance Lifesciences Limited on August 5, 2026. Cohance Lifesciences Limited is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“As indicated earlier, quarter 1 was a low quarter on both revenue and EBITDA. Our consolidated revenue from operations was $2-3 million, a decline of 23% year-on-year.”
“Let me take you through the financial performance. For FI26, revenue stood at $22.68 billion, a decline of approximately 13% year-on-year. The adjusted EBITDA stood at $4.77 billion.”
Cohance Lifesciences Limited
CFO
Transcript header (unverified)
Cohance Lifesciences Limited
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Earnings Call
Cohance Lifesciences Limited
Earnings Call for the Quarter Ended March 31, 2026
Cohance Lifesciences Limited
